![](https://www.Immune-System-Research.com/"wp-content/uploads"/2022/01/Fasiglifam-is-a-Selective-and-Orally-Active-GPR40-Agonist-2022-02-07-1600x914.png)
Fasiglifam (TAK-875) acts as a novel, orally available, selective GPR40 agonist. TAK-875 (0.01-10 μM) produces a concentration-dependent increase in intracellular…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2021/04/AMG-837-is-an-Orally-Active-and-Partial-Agonist-of-GPR40-FFA1-2021-04-20.jpg)
Free fatty acid receptor 1 (FFA1), also known as GPR40, is a class of G protein-coupled receptors. FFA1 strongly expresses…